ОбзорГрафикНовостиTraderScreen

Enzon Pharmaceuticals, Inc./  US2939041081  /

Nasdaq Other OTC
06.11.2024  17:36:04 Изменение - Объем сделки Бид- Предложение- Максимум Минимум
0.0850USD - 600
Оборот: 51		 -Величина цены спроса: - -Величина цены предложения: - 0.0850 0.0850
GlobeNewswire 24.01.2022 OTC Markets Group Announces the 2022 OTCQX Best 50
GlobeNewswire 06.01.2021 Silence Therapeutics Appoints Craig Tooman as Chief Financial Officer  
GlobeNewswire 04.01.2021 Enzon Pharmaceuticals, Inc. CEO Andrew Rackear to Retire; Richard L. Feinstein, Enzon’s CFO, to Assu...
GlobeNewswire 21.10.2020 Enzon Pharmaceuticals Announces Results of Rights Offering
GlobeNewswire 15.09.2020 Enzon Pharmaceuticals Announces Key Dates for Rights Offering
GlobeNewswire 02.09.2020 Enzon Pharmaceuticals, Inc. Announces Postponement of 2020 Annual Meeting
GlobeNewswire 21.08.2020 Enzon Pharmaceuticals Anticipated Rights Offering to Existing Shareholders
GlobeNewswire 14.08.2020 Enzon Pharmaceuticals, Inc. Adopts Tax Benefits Preservation Plan to Protect its NOL Assets and Shar...
GlobeNewswire 07.01.2020 Vyome Therapeutics Strengthens Executive Management with Appointment of Craig Tooman as Chief Operat...
GlobeNewswire 12.12.2019 Translate Bio Announces Executive Leadership Appointments
GlobeNewswire 01.11.2019 Ovid Therapeutics Announces Senior Management Promotions in Preparation for Multiple Data Readouts E...
GlobeNewswire 12.09.2019 Investigation Report on China's Pegaspargase Market, 2019-2023
GlobeNewswire 24.06.2019 CureVac Welcomes Two Members to its Supervisory Board
GlobeNewswire 18.03.2019 Motif Bio Announces Appointment of Bruce Williams as Interim Chairman and Resignation of Richard Mor...
GlobeNewswire 03.07.2018 Cancer Therapies: World Industry Analysis & Forecasts to 2030 - Key Company Profiles, Emerging Techn...
GlobeNewswire 20.04.2018 Global Malignant Melanoma Drug Market Report 2018: Dosage, Price & Clinical Pipeline Outlook 2024
GlobeNewswire 20.02.2007 Notice of AGM